SCHEMBL6328702

SCHEMBL6328702

NNC(=O)c1ccccc1C=O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CTSD P07339 2/20 0.50
CA1 P00915 1/20 0.50
CA2 P00918 1/20 0.50
CA9 Q16790 1/20 0.50
ALDH1A1 P00352 4/20 0.49
MEN1 O00255 3/20 0.46
KMT2A Q03164 3/20 0.46
TDP1 Q9NUW8 2/20 0.46
LMNA P02545 1/20 0.46
THRB P10828 1/20 0.46
BLM P54132 1/20 0.46
MAPT P10636 3/20 0.46
GAA P10253 2/20 0.46
MITF O75030 1/20 0.46
NCOA1 Q15788 1/20 0.46
NCOA3 Q9Y6Q9 1/20 0.46
P2RX7 Q99572 1/20 0.44
TRIM24 O15164 1/20 0.43
TRIM33 Q9UPN9 1/20 0.43
PTGDR2 Q9Y5Y4 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5477577 0.82 CTSD (0.49) CTSDCA1CA2CA9ALDH1A1
SCHEMBL11414557 0.82 CTSD (0.53) CTSDCA1CA2CA9ALDH1A1
SCHEMBL1932685 0.82 MEN1 (0.48) ALDH1A1MEN1KMT2ATDP1LMNA
SCHEMBL7542943 0.82 GAA (0.55) CA1CA9ALDH1A1MEN1KMT2A
SCHEMBL10279067 0.81 LMNA (0.43) ALDH1A1MEN1KMT2ATDP1LMNA
SCHEMBL14185996 0.80 MAOB (0.47) ALDH1A1MEN1KMT2ABLMMAOB
SCHEMBL30547074 0.80 CTSD (0.63) CTSDCA1CA2CA9ALDH1A1
SCHEMBL239328 0.80 CTSD (0.63) CTSDCA1CA2CA9ALDH1A1
SCHEMBL3419592 0.80 MEN1 (0.46) CA1CA9ALDH1A1MEN1KMT2A
SCHEMBL7199863 0.80 MEN1 (0.46) CA1CA9ALDH1A1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9221842-B2 Bicyclic methylene aziridines and reactions thereof WISCONSIN ALUMNI RESEARCH FOUNDATION (US) 2015-12-29 US disclosed
US-20080139560-A1 Ion Channel Modulators SCION PHARMACEUTICALS, INC. 2008-06-12 US disclosed
US-20050075323-A1 Beta3 adrenergic receptor agonists and uses thereof PFIZER INC 2005-04-07 US disclosed
US-6706743-B2 β3 adrenergic receptor agonists and uses thereof PFIZER INC 2004-03-16 US disclosed
US-20030203913-A1 Beta3 adrenergic receptor agonists and uses thereof PFIZER INC. 2003-10-30 US disclosed
EP-1326861-A1 ALPHA-ARYL ETHANOLAMINES AND THEIR USE AS BETA-3 ADRENERGIC RECEPTOR AGONISTS Pfizer Products Inc. (US) 2003-07-16 EP disclosed
US-6566377-B2 β3 adrenergic receptor agonists and uses thereof PFIZER INC. 2003-05-20 US disclosed
US-20020094993-A1 Compositions for repelling crawling insects S.C. JOHNSON & SON, INC. 2002-07-18 US disclosed
EP-0527517-B1 Photographic direct positive material containing a masked benzotriazole stabilizer AGFA GEVAERT (BE) 2002-07-03 EP disclosed
US-20020052392-A1 Bita3 adrenergic receptor agonists and uses thereof DAY ROBERT F (US) 2002-05-02 US disclosed
US-5254443-A Photographic direct positive material containing a masked benzotriazole stabilizer AGFA-GEVAERT, N.V. (BE) 1993-10-19 US disclosed
US-5190974-A Analgesics ROUSSEL UCLAF (FR) 1993-03-02 US disclosed
EP-0527517-A1 Photographic direct positive material containing a masked benzotriazole stabilizer AGFA-GEVAERT N.V. (BE) 1993-02-17 EP disclosed
EP-0496127-A1 A negative type lithographic printing plate based on silver salt diffusion transfer AGFA-GEVAERT N.V. (BE) 1992-07-29 EP disclosed
US-5117057-A Insecticidal N' substituted-N-N'-disubstituted-hydrazines ROHM AND HAAS COMPANY (US) 1992-05-26 US disclosed
EP-0481562-A1 A negative type lithographic printing plate AGFA-GEVAERT N.V. (BE) 1992-04-22 EP disclosed
EP-0473209-A1 Method of making direct-positive computer output images AGFA-GEVAERT N.V. (BE) 1992-03-04 EP disclosed
EP-0465369-A1 N-substituted derivatives of alpha-mercapto alkylamines, process for their preparation and intermediates obtained, their use as medicaments and compositions containing them ROUSSEL-UCLAF (FR) 1992-01-08 EP disclosed
US-4358528-A Formation of black-and-white silver-containing negative images by a diffusion transfer process FUJI PHOTO FILM CO., LTD. (JP) 1982-11-09 US disclosed
US-4309499-A PROCESSING WITH ONE SOLUTION CONTAINING FOGGING AGENT, FOG PROMOTER, DEVELOPER, AND SOLVENT FOR SILVER HALIDE FUJI PHOTO FILM CO., LTD. (JP) 1982-01-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030203913-A1 Beta3 adrenergic receptor agonists and uses thereof ADRB3, ADRB1, ADRB2 CTSD 4059/4885CA1 4180/4885CA2 2428/4885
US-20050075323-A1 Beta3 adrenergic receptor agonists and uses thereof ADRB3, ADRB1, ADRB2 CTSD 4018/4885CA1 4497/4885CA2 2810/4885
US-20080139560-A1 Ion Channel Modulators CACNA1B, CACNA1C, TRPV1 CTSD 2337/4885CA1 869/4885CA2 183/4885
US-20020052392-A1 Bita3 adrenergic receptor agonists and uses thereof ADRB3, ADRA1A, ADRB1 CTSD 4073/4885CA1 4537/4885CA2 3005/4885
US-20020094993-A1 Compositions for repelling crawling insects ACHE, DDT, GAP43 CTSD 836/4885CA1 1889/4885CA2 1428/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.